Esther Mazario-Martín

Esther Mazario-Martín

Auto-generated profile, based on publicly available information

Esther Mazario-Martín

Servicio de Pediatría, Hospital Universitario de Guadalajara, Guadalajara, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2023 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
CPCarlos Pita-Martínez
Carlos Pita-Martínez
CGCarmen Goez-Sanz
Carmen Goez-Sanz
AVAna Virseda-Berdices
Ana Virseda-Berdices
AGAlejandro Gonzalez-Praetorius
Alejandro Gonzalez-Praetorius
EMEsther Mazario-Martín
Esther Mazario-Martín
IMIsidoro Martinez
Isidoro Martinez
We aimed to analyze whether the expression of inflammatory and antiviral genes in respiratory syncytial virus (RSV)-infected infants' peripheral blood is associated with bronchiolitis progression. We conducted a prospective study on 117 infants between 2015 and 2023. The expression levels of nine genes were quantified by quantitative polymerase chain reaction. Infants were classified according to their clinical evolution during hospital admission: (i) non-progression (n = 74), when the RSV bronchiolitis severity remained stable or improved; (ii) unfavorable progression (n = 43), when the RSV bronchiolitis severity increased. The association analysis was performed by logistic regression, adjusted by age, gender, prematurity, and RSV bronchiolitis severity in the emergency room. Infants were 57.3% male, and the median age of the study population was 61 days. Thirty-five infants (30.7%) were admitted to the intensive care unit after hospital admission. Univariate logistic models showed that tumor necrosis factor (TNFα) and chemokine (C-C motif) ligand (CCL5) gene expression at baseline were inversely associated with unfavorable progression, which was confirmed by multivariate analyses: TNFα (adjusted odds ratio = 0.8 [95% confidence interval = 0.64-0.99], P-value = 0.038) and CCL5 (adjusted odds ratio = 0.76 [95% confidence interval = 0.62-0.93], P-value = 0.007). An inadequate immune response to RSV, characterized by reduced gene expression levels of CCL5 and TNFα in peripheral blood, was associated with an unfavorable progression of RSV bronchiolitis.